Materials in particulate form for tissue engineering. 1. Basic concepts

被引:81
作者
Silva, G. A. [1 ,2 ]
Ducheyne, P. [3 ]
Reis, R. L. [1 ,2 ]
机构
[1] Univ Minho, Dept Polymer Engn, P-4800058 Guimaraes, Portugal
[2] Univ Minho, Res Grp Biomat Biodegradables Biomimet 3Bs, P-4710057 Braga, Portugal
[3] Univ Penn, Ctr Bioact Mat & Tissue Engn, Philadelphia, PA 19104 USA
关键词
microparticles; nanoparticles; drug delivery; tissue engineering; polymers; ceramics; natural origin;
D O I
10.1002/term.2
中图分类号
Q813 [细胞工程];
学科分类号
摘要
For biomedical applications, materials small in size are growing in importance. In an era where 'nano' is the new trend, micro- and nano-materials are in the forefront of developments. Materials in the particulate form aim to designate systems with a reduced size, such as micro- and nanoparticles. These systems can be produced starting from a diversity of materials, of which polymers are the most used. Similarly, a multitude of methods are used to produce particulate systems, and both materials and methods are critically reviewed here. Among the varied applications that materials in the particulate form can have, drug delivery systems are probably the most prominent, as these have been in the forefront of interest for biomedical applications. The basic concepts pertaining to drug delivery are summarized, and the role of polymers as drug delivery systems conclude this review. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:4 / 24
页数:21
相关论文
共 330 条
[81]  
Gaspar MM, 1998, J CONTROL RELEASE, V52, P53
[82]   ANALYSIS OF THE IN-VIVO REACTIONS OF A BIOACTIVE GLASS IN SOFT AND HARD-TISSUE [J].
GATTI, AM ;
VALDRE, G ;
ANDERSSON, OH .
BIOMATERIALS, 1994, 15 (03) :208-212
[83]   Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture [J].
Genzel, Y ;
Behrendt, I ;
König, S ;
Sann, H ;
Reichl, U .
VACCINE, 2004, 22 (17-18) :2202-2208
[84]   Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS) [J].
Ghaderi, R ;
Artursson, P ;
Carlfors, J .
PHARMACEUTICAL RESEARCH, 1999, 16 (05) :676-681
[85]   Dexamethasone-loaded magnetic albumin microspheres: Preparation and in vitro release [J].
Ghassabian, S ;
Ehtezazi, T ;
Forutan, SM ;
Mortazavi, SA .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 130 (01) :49-55
[86]  
Gibaud S, 2004, INT J PHARM, V269, P491, DOI 10.1016/j.ijpharm.2003.09.040
[87]   Preparation of 3,4-diaminopyridine microparticles by solvent-evaporation methods [J].
Gibaud, S ;
Bonneville, A ;
Astier, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) :197-201
[88]   Slow-release melarsoprol microparticles [J].
Gibaud, S ;
Gaia, A ;
Astier, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 243 (1-2) :161-166
[89]   Protein release from alginate matrices [J].
Gombotz, WR ;
Wee, SF .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) :267-285
[90]   A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour [J].
Gomes, ME ;
Ribeiro, AS ;
Malafaya, PB ;
Reis, RL ;
Cunha, AM .
BIOMATERIALS, 2001, 22 (09) :883-889